Literature DB >> 6163960

Production, partial purification and characterization of human and murine interferons--type II.

M Wiranowska-Stewart, L S Lin, I A Braude, W E Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6163960     DOI： 10.1016/0161-5890(80)90160-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN： 0161-5890            Impact factor:   4.407


× No keyword cloud information.
  7 in total

1.  Monoclonal antibodies against murine gamma interferon.

Authors:  M Prat; G Gribaudo; P M Comoglio; G Cavallo; S Landolfo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

2.  Partial characterization of gamma (immune) interferon mRNA extracted from human lymphocytes.

Authors:  T Taniguchi; R H Pang; Y K Yip; D Henriksen; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

3.  Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.

Authors:  B Y Rubin; S L Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

4.  Partial purification and characterization of human gamma (immune) interferon.

Authors:  Y K Yip; R H Pang; C Urban; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

5.  Spontaneous production of gamma interferon and induced production of beta interferon by human T-lymphoblastoid cell lines.

Authors:  A G Morris; J Morser; A Meager
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  Streptococcal cell walls and synovial cell activation. Stimulation of synovial fibroblast plasminogen activator activity by monocytes treated with group A streptococcal cell wall sonicates and muramyl dipeptide.

Authors:  J A Hamilton; J B Zabriskie; L B Lachman; Y S Chen
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

7.  Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.

Authors:  P S Steeg; R N Moore; H M Johnson; J J Oppenheim
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.